HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ian Brown Selected Research
Ian Brown Research Topics
Disease
12
Neoplasms (Cancer)
01/2022 - 02/2004
7
Adenocarcinoma
01/2022 - 09/2010
4
Adenoma (Adenomas)
01/2020 - 03/2016
3
Prostatic Neoplasms (Prostate Cancer)
01/2022 - 01/2020
3
Barrett Esophagus (Barrett's Esophagus)
01/2022 - 12/2018
3
Obesity
01/2022 - 01/2008
3
Inflammation (Inflammations)
01/2022 - 01/2018
3
Polyps
01/2020 - 03/2016
2
Colitis
01/2021 - 01/2021
2
Melanoma (Melanoma, Malignant)
03/2005 - 02/2004
1
Virus Diseases (Viral Diseases)
07/2022
1
Cardiovascular Diseases (Cardiovascular Disease)
01/2022
1
Hypertriglyceridemia
01/2022
1
COVID-19
01/2022
1
Hypertension (High Blood Pressure)
01/2022
1
Genomic Instability
11/2021
1
Metaplasia
01/2020
1
Carcinoma (Carcinomatosis)
01/2020
1
Colonic Polyps
01/2020
1
Gastroesophageal Reflux (GERD)
01/2020
1
Paraproteinemias (Monoclonal Gammopathy)
01/2019
1
Disease Progression
12/2018
1
Granuloma
01/2018
1
Sepsis (Septicemia)
01/2015
1
Enterocolitis
06/2014
1
Dehydration (Water Stress)
03/2014
1
Diarrhea
03/2014
1
Diabetes Complications
01/2012
1
Type 2 Diabetes Mellitus (MODY)
01/2012
1
Cognitive Dysfunction
01/2012
1
Ileitis
08/2011
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2010
1
Epilepsy (Aura)
12/2009
1
Status Epilepticus (Complex Partial Status Epilepticus)
12/2009
1
Squamous Cell Carcinoma of Head and Neck
06/2009
1
Lymphoma (Lymphomas)
05/2005
1
Infections
07/2004
Drug/Important Bio-Agent (IBA)
4
Antigens
IBA
01/2018 - 02/2004
3
Proteins (Proteins, Gene)
FDA Link
07/2022 - 02/2004
3
Androgens
IBA
01/2022 - 01/2020
3
Lipids
IBA
01/2022 - 03/2013
3
DNA (Deoxyribonucleic Acid)
IBA
11/2021 - 01/2020
3
Catenins
IBA
01/2018 - 03/2016
3
Neoplasm Antigens (Tumor Antigens)
IBA
03/2005 - 02/2004
2
Biomarkers (Surrogate Marker)
IBA
01/2020 - 12/2018
2
theasinensin A
IBA
01/2020 - 03/2016
2
Glucose (Dextrose)
FDA Link
Generic
03/2013 - 01/2012
1
Pharmaceutical Preparations
IBA
07/2022
1
HDL Cholesterol
IBA
01/2022
1
Bile Acids and Salts (Bile Acids)
IBA
01/2022
1
Complement Membrane Attack Complex (Membrane Attack Complex)
IBA
01/2022
1
Complement System Proteins (Complement)
IBA
01/2022
1
Fatty Acids (Saturated Fatty Acids)
IBA
01/2022
1
Hemoglobins (Hemoglobin)
IBA
01/2022
1
Testosterone (Sustanon)
FDA Link
01/2022
1
Immune Checkpoint Inhibitors
IBA
01/2021
1
Biological Products
IBA
01/2021
1
Drinking Water
IBA
01/2020
1
Lysophospholipids
IBA
01/2020
1
Agrin
IBA
01/2020
1
Ceramides
IBA
01/2020
1
Deoxycholic Acid (Sodium Deoxycholate)
IBA
01/2020
1
Phenobarbital (Luminal)
FDA Link
01/2020
1
Paraproteins
IBA
01/2019
1
Lectins
IBA
12/2018
1
Glycoproteins (Glycoprotein)
IBA
12/2018
1
Mucins
IBA
05/2018
1
alpha-Fetoproteins (alpha-Fetoprotein)
IBA
03/2018
1
Guanosine
IBA
03/2016
1
Phosphates (Orthophosphate)
IBA
03/2016
1
Cytosine
IBA
03/2016
1
Anti-Bacterial Agents (Antibiotics)
IBA
01/2015
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2015
1
DNA Transposable Elements (Element, IS)
IBA
01/2015
1
Immunosuppressive Agents (Immunosuppressants)
IBA
01/2015
1
olmesartan
IBA
06/2014
1
Solutions
IBA
03/2014
1
ORALIT (ORS)
IBA
03/2014
1
Insulin (Novolin)
FDA Link
01/2012
1
Collagen
IBA
08/2011
1
Crystallins (Crystallin)
IBA
03/2010
1
Tablets
IBA
12/2009
1
Anticonvulsants (Antiepileptic Drugs)
IBA
12/2009
1
Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)
IBA
06/2009
1
Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)
IBA
03/2005
1
Nucleotides
IBA
07/2004
1
Nucleoproteins
IBA
07/2004
1
Amino Acids
FDA Link
07/2004
Therapy/Procedure
7
Therapeutics
01/2022 - 06/2004
2
Colectomy
01/2021 - 10/2018
1
Personal Protective Equipment
01/2022
1
Immunotherapy
01/2021
1
Biological Therapy
01/2021
1
Fluid Therapy (Oral Rehydration Therapy)
03/2014
1
Neoadjuvant Therapy
09/2010
1
Lymph Node Excision (Lymph Node Dissection)
09/2010
1
Esophagectomy
09/2010
1
Micro-Electrical-Mechanical Systems
12/2009
1
Primary Care Nursing
01/2008
1
Radiotherapy
05/2005